Department of Bone Tumor, 307th Hospital of PLA, Beijing 100071, People's Republic of China.
Pathol Oncol Res. 2012 Jul;18(3):629-33. doi: 10.1007/s12253-011-9487-3. Epub 2011 Dec 16.
To investigate the effect of preoperative induction chemotherapy on treatment of recurrent liposarcoma. 21 patients with recurrent liposarcoma received the treatment of preoperative intra-arterial chemotherapy and surgical resection. Intra-arterial chemotherapy was given by subcutaneous implantable drug delivery system with infusion of cisplatin and doxorubicin followed by caffeine. After treatment, patients were followed up for 39 months. The liposarcoma changes in CT imaging were observed in 18 cases and there were 15 cases with medium or severe pathological changes caused by chemotherapy. At the end of the postoperative follow-up of 39 months, liposarcoma reoccurred locally in 2 cases; pulmonary metastasis occurred in 1 case and death in 3 cases. Preoperative intra-arterial chemotherapy is effective for highly malignant tumors such as recurrent liposarcoma and the judgment of prognosis is based on the postoperative pathological changes of such tumor.
研究术前诱导化疗对复发性脂肪肉瘤治疗的影响。21 例复发性脂肪肉瘤患者接受术前动脉内化疗和手术切除治疗。采用皮下植入式药物输送系统输注顺铂和多柔比星,随后给予咖啡因进行动脉内化疗。治疗后,对患者进行了 39 个月的随访。18 例患者的 CT 影像学显示脂肪肉瘤发生变化,其中 15 例患者因化疗出现中度或重度病理变化。术后 39 个月随访结束时,2 例患者局部复发性脂肪肉瘤;1 例发生肺转移,3 例死亡。术前动脉内化疗对高度恶性肿瘤如复发性脂肪肉瘤有效,预后判断基于此类肿瘤术后的病理变化。